Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2025-08-18 00:00:00 ET · period of report 2025-08-18 · accession 0001773152-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-18 | 2025-08-18 | ANIP | Leonard Matthew J | Dir | S - Sale | $88.17 | -6,937 | 9,392 | -42% | -$611.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-18 | S | D | 6,937 | $88.17 | 9,392 | D | — | — | (F1) The shares were sold in multiple trades at prices ranging from $87.66 to $88.36. The price reported above reflects the weighted average sales price. |